Tiziano Russo1, Antonio Pizuorno2, Gholamreza Oskrochi2, Giovanni Latella3, Sara Massironi4, Mario Schettino5, Alessio Aghemo6, Nicola Pugliese6, Hassan Brim1, Hassan Ashktorab1. 1. Department of Medicine, Department of Pathology and Cancer Center, Department of Biochemistry & Molecular Biology, Howard University College of Medicine, Washington DC. 2. College of Engineering and Technology, American University of the Middle East, Kuwait. 3. Gastroenterology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy. 4. Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, and European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy. 5. Gastroenterology Unit, ASST Rhodense, Garbagnate Milanese, Lombardia, Italy. 6. Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy.
Abstract
Background: Italy was the first country in Europe to report a SARS-CoV-2 case. Since then, the country has suffered a large number of COVID-19 infections both in adults and children. This disease has been shown to lead to different outcomes in these two groups, which often present varying symptoms and comorbidities. Aim: Therefore, we aimed to evaluate the symptoms, comorbidities and laboratory values in adults and children. Methods: We present the characteristics of 1,324 adults and 563 pediatric COVID-19 Italian patients. The data was retrieved from studies published in Italy and found via PubMed and Google Scholar. Results: The virus appeared to affect adults more than children and men more than women, and to result in more severe outcomes in patients with abnormal laboratory values and a higher number of comorbidities. Adults are at higher risk for complications and death, and they usually present with fever, respiratory symptoms, cough, fatigue, diarrhea, myalgia, and/or loss of taste, smell, or appetite. Children usually have a milder disease progression and usually present with fever, cough, rhinorrhea, pharyngitis, sore throat, pneumonia, GI symptoms (diarrhea, vomiting, abdominal pain), fatigue, and dyspnea. Conclusion: Our findings support early reports that showed that SARS-CoV-2 is associated with more common asymptomatic cases and milder clinical outcome in children than in adults. Acute respiratory distress syndrome and Multisystem inflammatory syndrome in children (systemic vasculitis) are the most severe disease progressions for adults and children, respectively.
Background: Italy was the first country in Europe to report a SARS-CoV-2 case. Since then, the country has suffered a large number of COVID-19 infections both in adults and children. This disease has been shown to lead to different outcomes in these two groups, which often present varying symptoms and comorbidities. Aim: Therefore, we aimed to evaluate the symptoms, comorbidities and laboratory values in adults and children. Methods: We present the characteristics of 1,324 adults and 563 pediatric COVID-19 Italian patients. The data was retrieved from studies published in Italy and found via PubMed and Google Scholar. Results: The virus appeared to affect adults more than children and men more than women, and to result in more severe outcomes in patients with abnormal laboratory values and a higher number of comorbidities. Adults are at higher risk for complications and death, and they usually present with fever, respiratory symptoms, cough, fatigue, diarrhea, myalgia, and/or loss of taste, smell, or appetite. Children usually have a milder disease progression and usually present with fever, cough, rhinorrhea, pharyngitis, sore throat, pneumonia, GI symptoms (diarrhea, vomiting, abdominal pain), fatigue, and dyspnea. Conclusion: Our findings support early reports that showed that SARS-CoV-2 is associated with more common asymptomatic cases and milder clinical outcome in children than in adults. Acute respiratory distress syndrome and Multisystem inflammatory syndrome in children (systemic vasculitis) are the most severe disease progressions for adults and children, respectively.
Authors: Marta Colaneri; Paolo Sacchi; Valentina Zuccaro; Simona Biscarini; Michele Sachs; Silvia Roda; Teresa Chiara Pieri; Pietro Valsecchi; Antonio Piralla; Elena Seminari; Angela Di Matteo; Stefano Novati; Laura Maiocchi; Layla Pagnucco; Marcello Tirani; Fausto Baldanti; Francesco Mojoli; Stefano Perlini; Raffaele Bruno Journal: Euro Surveill Date: 2020-04
Authors: Christopher T Rentsch; Farah Kidwai-Khan; Janet P Tate; Lesley S Park; Joseph T King; Melissa Skanderson; Ronald G Hauser; Anna Schultze; Christopher I Jarvis; Mark Holodniy; Vincent Lo Re; Kathleen M Akgün; Kristina Crothers; Tamar H Taddei; Matthew S Freiberg; Amy C Justice Journal: PLoS Med Date: 2020-09-22 Impact factor: 11.069
Authors: Alexandra E Livanos; Divya Jha; Francesca Cossarini; Ana S Gonzalez-Reiche; Minami Tokuyama; Teresa Aydillo; Tommaso L Parigi; Mark S Ladinsky; Irene Ramos; Katie Dunleavy; Brian Lee; Rebekah E Dixon; Steven T Chen; Gustavo Martinez-Delgado; Satish Nagula; Emily A Bruce; Huaibin M Ko; Benjamin S Glicksberg; Girish Nadkarni; Elisabet Pujadas; Jason Reidy; Steven Naymagon; Ari Grinspan; Jawad Ahmad; Michael Tankelevich; Yaron Bram; Ronald Gordon; Keshav Sharma; Jane Houldsworth; Graham J Britton; Alice Chen-Liaw; Matthew P Spindler; Tamar Plitt; Pei Wang; Andrea Cerutti; Jeremiah J Faith; Jean-Frederic Colombel; Ephraim Kenigsberg; Carmen Argmann; Miriam Merad; Sacha Gnjatic; Noam Harpaz; Silvio Danese; Carlos Cordon-Cardo; Adeeb Rahman; Robert E Schwartz; Nikhil A Kumta; Alessio Aghemo; Pamela J Bjorkman; Francesca Petralia; Harm van Bakel; Adolfo Garcia-Sastre; Saurabh Mehandru Journal: Gastroenterology Date: 2021-03-04 Impact factor: 33.883